Category: Clinical Breakthroughs
-
New Biomarkers for Glioma Treatment Response
Biomarkers using mass cytometry can assess patient response to an emerging treatment for pediatric brain tumors, according to a recent multi-center study.
-
Mixed Record on Lifestyle Advice for Pediatric Fatty Liver
Lifestyle advice has been only somewhat effective in controlling or slowing the progression of nonalcoholic fatty liver disease in children, according to a recent study published in Gastroenterology.
-
Advancing Deep Brain Stimulation for Parkinson’s
A novel deep brain stimulation device significantly improved quality of life for patients with advanced Parkinson’s disease while also reducing common physical side effects from medication, according to findings published in The Lancet Neurology.
-
Northwestern Takes on COVID-19 Antibody Testing
At Northwestern Medicine, various COVID-19 antibody testing efforts have been underway since the beginning of the pandemic.
-
Assessing Risk Factors in Critically Ill COVID-19 Patients
Certain factors are associated with increased risk of death in critically ill COVID-19 patients, according to recent Northwestern Medicine studies.
-
Drug Proves Ineffective in Slowing Diabetic Kidney Disease
A drug commonly used to reduce serum urate levels proved ineffective in slowing disease progression in patients with diabetic kidney disease, according to a recent study.
-
Heart Failure, Hypertensive Deaths Rise in Black Women and Men
Deaths due to heart failure and hypertensive heart disease are increasing in the U.S. — particularly in Black women and men — despite medical and surgical advances in heart disease management, according to a new Northwestern Medicine study.
-
Shortened Resident Shifts Didn’t Decrease Errors
Residents working shifts of 16 hours or less didn’t make fewer errors than residents assigned to 24-hour shifts, according to a recent study published in NEJM.
-
Continuous Glucose Monitoring May Help Reduce Hypoglycemia
In older adults with type 1 diabetes, continuous blood glucose monitoring was more effective in reducing hypoglycemia than standard blood glucose monitoring, according to recent findings published in JAMA.
-
Drug Shortens Flu Recovery in Vulnerable Patients
Patients with influenza at risk of complications recovered more quickly after early treatment with the drug baloxavir marboxil, according to a study published in The Lancet Infectious Diseases.
